Loading...
SN. logo

Smith & Nephew plcLSE:SN. Stock Report

Market Cap UK£10.8b
Share Price
UK£12.71
My Fair Value
n/a
1Y35.5%
7D-9.0%
Portfolio Value
View

Smith & Nephew plc

LSE:SN. Stock Report

Market Cap: UK£10.8b

Smith & Nephew (SN.) Stock Overview

Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. More details

SN. fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance3/6
Financial Health4/6
Dividends5/6

SN. Community Fair Values

Create Narrative

See what 56 others think this stock is worth. Follow their fair value or set your own to get alerts.

Smith & Nephew plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Smith & Nephew
Historical stock prices
Current Share PriceUK£12.71
52 Week HighUK£14.42
52 Week LowUK£9.30
Beta0.65
1 Month Change-4.04%
3 Month Change-5.57%
1 Year Change35.53%
3 Year Change19.45%
5 Year Change-15.58%
Change since IPO6,312.46%

Recent News & Updates

Do Smith & Nephew's (LON:SN.) Earnings Warrant Your Attention?

Oct 14
Do Smith & Nephew's (LON:SN.) Earnings Warrant Your Attention?

Recent updates

Do Smith & Nephew's (LON:SN.) Earnings Warrant Your Attention?

Oct 14
Do Smith & Nephew's (LON:SN.) Earnings Warrant Your Attention?

Is Smith & Nephew (LON:SN.) A Risky Investment?

Sep 30
Is Smith & Nephew (LON:SN.) A Risky Investment?

We Like These Underlying Return On Capital Trends At Smith & Nephew (LON:SN.)

Aug 28
We Like These Underlying Return On Capital Trends At Smith & Nephew (LON:SN.)

We Think Smith & Nephew's (LON:SN.) Robust Earnings Are Conservative

Aug 12
We Think Smith & Nephew's (LON:SN.) Robust Earnings Are Conservative

Smith & Nephew plc Just Beat EPS By 26%: Here's What Analysts Think Will Happen Next

Aug 08
Smith & Nephew plc Just Beat EPS By 26%: Here's What Analysts Think Will Happen Next

Estimating The Fair Value Of Smith & Nephew plc (LON:SN.)

Aug 04
Estimating The Fair Value Of Smith & Nephew plc (LON:SN.)

Smith & Nephew plc's (LON:SN.) Popularity With Investors Is Clear

Jun 27
Smith & Nephew plc's (LON:SN.) Popularity With Investors Is Clear

Smith & Nephew (LON:SN.) Is Finding It Tricky To Allocate Its Capital

May 24
Smith & Nephew (LON:SN.) Is Finding It Tricky To Allocate Its Capital

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

May 09
We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 21%?

Apr 24
Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 21%?
User avatar

Restructuring Will Improve Operating Efficiency By 2025

Strategic restructuring and innovative platforms like CORI and REGENETEN are enhancing revenue growth and operational efficiency, impacting margins positively as macroeconomic conditions stabilize.

Shareholders Should Be Pleased With Smith & Nephew plc's (LON:SN.) Price

Mar 14
Shareholders Should Be Pleased With Smith & Nephew plc's (LON:SN.) Price

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 67% Above Its Share Price

Jan 03
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 67% Above Its Share Price

Does Smith & Nephew (LON:SN.) Have A Healthy Balance Sheet?

Dec 15
Does Smith & Nephew (LON:SN.) Have A Healthy Balance Sheet?

Shareholder Returns

SN.GB Medical EquipmentGB Market
7D-9.0%-6.3%0.6%
1Y35.5%21.8%18.8%

Return vs Industry: SN. exceeded the UK Medical Equipment industry which returned 21.6% over the past year.

Return vs Market: SN. exceeded the UK Market which returned 17.5% over the past year.

Price Volatility

Is SN.'s price volatile compared to industry and market?
SN. volatility
SN. Average Weekly Movement3.8%
Medical Equipment Industry Average Movement5.3%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.6%

Stable Share Price: SN. has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: SN.'s weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
185617,000Deepak Nathwww.smith-nephew.com

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Smith & Nephew plc Fundamentals Summary

How do Smith & Nephew's earnings and revenue compare to its market cap?
SN. fundamental statistics
Market capUK£10.77b
Earnings (TTM)UK£373.21m
Revenue (TTM)UK£4.52b
28.9x
P/E Ratio
2.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SN. income statement (TTM)
RevenueUS$5.94b
Cost of RevenueUS$1.75b
Gross ProfitUS$4.20b
Other ExpensesUS$3.71b
EarningsUS$491.00m

Last Reported Earnings

Jun 28, 2025

Next Earnings Date

Mar 02, 2026

Earnings per share (EPS)0.58
Gross Margin70.59%
Net Profit Margin8.26%
Debt/Equity Ratio58.6%

How did SN. perform over the long term?

See historical performance and comparison

Dividends

2.3%
Current Dividend Yield
68%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/10 04:38
End of Day Share Price 2025/11/10 00:00
Earnings2025/06/28
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Smith & Nephew plc is covered by 40 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sally TaylorBarclays
Hassan Al-WakeelBarclays
Samuel EnglandBerenberg